Philips to pay SEC $62m for corrupt China sales

Philips has been ordered to pay $62m to resolve charges brought by the US Securities and Exchange Commission (SEC) that the Dutch medical supplier breached the Foreign Corrupt Practices Act (FCPA) in sales of medical diagnost...

Want to read this article?

Register for ultimate access to this article and ALL our premium content


  • Unrestricted access to Commercial Risk, Commercial Risk Europe and Global Risk Manager news, exclusive expert analysis and opinion
  • Breaking news, daily and/or weekly Commercial Risk Europe newsletters and regular digital publications
  • Breaking news, weekly and monthly Global Risk Manager newsletters and quarterly digital Journal
  • European and global surveys, rankings and special reports
  • National European local language newsletters
  • Preferential access to webinars and virtual and physical conferences

If you are already a registered user or subscriber you can LOGIN below for ultimate access:

Back to top button